Literature DB >> 34379529

Identification of Staphylococcus pseudintermedius Isolates from Wound Cultures by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry Improves Accuracy of Susceptibility Reporting at an Increase in Cost.

Helen L Bibby1, Kristen L Brown1,2.   

Abstract

Staphylococcus pseudintermedius can easily be mistaken for Staphylococcus aureus using phenotypic and rapid biochemical methods. We began confirming the identification of all coagulase-positive staphylococci isolated from human wound cultures at our centralized laboratory, servicing both community and inpatients, with matrix-assisted laser desorption ionization-time of flight mass spectrometry instead of using phenotypic and rapid biochemical tests, and determined the prevalence of S. pseudintermedius since the change in identification procedure and at what cost. A retrospective review was performed on all wound swab cultures from which coagulase-positive staphylococci were isolated 7 months before and after the change in identification procedure. A total of 49 S. intermedius/pseudintermedius (SIP) isolates were identified, including 7 isolates from 14,401 wound cultures in the before period and 42 isolates from 14,147 wound cultures in the after period. The number of SIP isolates as a proportion of isolated coagulase-positive staphylococci increased significantly from the before, 7/6,351 (0.1%), to the after, 42/5,435 (0.7%), period (difference, 0.6% [95% confidence interval, 0.037 to 0.83%, P < 0.0001]). Antibiotic susceptibility testing was performed in 42 isolates; none had an oxacillin MIC of 1.0 to 2.0 μg/ml, the range in which, if the isolate was misidentified as S. aureus, a very major error in susceptibility interpretation would occur. The increase in cost of the change in identification procedure was Can$17,558 per year in our laboratory, performing microbiology testing for community and acute-care patients in a zone servicing nearly 1.7 million people. While we will only continue to learn more about this emerging pathogen if we make attempts to properly identify it in clinical cultures, the additional time and cost involved may be unacceptably high in some laboratories.  .

Entities:  

Keywords:  Staphylococcus pseudintermedius; human infection; methicillin resistance; quality improvement

Mesh:

Year:  2021        PMID: 34379529      PMCID: PMC8525577          DOI: 10.1128/JCM.00973-21

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  19 in total

1.  Epidemiology, Clinical Characteristics, and Antimicrobial Susceptibility Profiles of Human Clinical Isolates of Staphylococcus intermedius Group.

Authors:  Melanie L Yarbrough; William Lainhart; C A Burnham
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

2.  Human infections due to Staphylococcus pseudintermedius, an emerging zoonosis of canine origin: report of 24 cases.

Authors:  R Somayaji; M A R Priyantha; J E Rubin; D Church
Journal:  Diagn Microbiol Infect Dis       Date:  2016-05-12       Impact factor: 2.803

3.  First case of Staphylococcus pseudintermedius infection in a human.

Authors:  Lieve Van Hoovels; Anne Vankeerberghen; An Boel; Kristien Van Vaerenbergh; Hans De Beenhouwer
Journal:  J Clin Microbiol       Date:  2006-10-18       Impact factor: 5.948

4.  Methicillin-resistant Staphylococcus aureus (MRSA) and methicillin-resistant Staphylococcus pseudintermedius (MRSP) among employees and in the environment of a small animal hospital.

Authors:  Andrea T Feßler; Riccarda Schuenemann; Kristina Kadlec; Vivian Hensel; Julian Brombach; Jayaseelan Murugaiyan; Gerhard Oechtering; Iwan A Burgener; Stefan Schwarz
Journal:  Vet Microbiol       Date:  2018-06-08       Impact factor: 3.293

5.  A spinal infection with Staphylococcus pseudintermedius.

Authors:  Christopher A Darlow; Nikolaos Paidakakos; Murtuza Sikander; Bridget Atkins
Journal:  BMJ Case Rep       Date:  2017-08-07

6.  Zoonotic Staphylococcus pseudintermedius sinonasal infections: risk factors and resistance patterns.

Authors:  Elisabeth H Ference; Arman Danielian; Han Wool Kim; Fredrick Yoo; Edward C Kuan; Jeffrey D Suh
Journal:  Int Forum Allergy Rhinol       Date:  2019-03-25       Impact factor: 3.858

7.  Identification of Staphylococcus intermedius Group by MALDI-TOF MS.

Authors:  Paola Decristophoris; Amy Fasola; Cinzia Benagli; Mauro Tonolla; Orlando Petrini
Journal:  Syst Appl Microbiol       Date:  2011-02       Impact factor: 4.022

8.  Species differentiation within the Staphylococcus intermedius group using a refined MALDI-TOF MS database.

Authors:  J Murugaiyan; B Walther; I Stamm; Y Abou-Elnaga; S Brueggemann-Schwarze; S Vincze; L H Wieler; A Lübke-Becker; T Semmler; U Roesler
Journal:  Clin Microbiol Infect       Date:  2014-06-14       Impact factor: 8.067

9.  Evaluation of Oxacillin and Cefoxitin Disk and MIC Breakpoints for Prediction of Methicillin Resistance in Human and Veterinary Isolates of Staphylococcus intermedius Group.

Authors:  M T Wu; C-A D Burnham; L F Westblade; J Dien Bard; S D Lawhon; M A Wallace; T Stanley; E Burd; J Hindler; R M Humphries
Journal:  J Clin Microbiol       Date:  2015-11-25       Impact factor: 5.948

10.  Longitudinal study on methicillin-resistant Staphylococcus pseudintermedius in households.

Authors:  Laura M Laarhoven; Phebe de Heus; Jeanine van Luijn; Birgitta Duim; Jaap A Wagenaar; Engeline van Duijkeren
Journal:  PLoS One       Date:  2011-11-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.